Evidence map›Paper›PMID 28929951›Full record

ArticleToxicologic pathology2018

The Fate of Inhaled Nanoparticles: Detection and Measurement by Enhanced Dark-field Microscopy.

Robert R Mercer, James F Scabilloni, Liying Wang, Lori A Battelli, James M Antonini, Jenny R Roberts, Yong Qian, Jennifer D Sisler, Vincent Castranova, Dale W Porter and 1 more

Open access · bronzeAbstract read
In one paragraph

Article in Toxicologic pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 28 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Robert R Mercer1 Pathology and Physiology Research Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
James F Scabilloni1 Pathology and Physiology Research Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
Liying Wang3 Allergy and Clinical Immunology Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
Lori A Battelli1 Pathology and Physiology Research Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
James M Antonini3 Allergy and Clinical Immunology Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
Jenny R Roberts3 Allergy and Clinical Immunology Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
Yong Qian3 Allergy and Clinical Immunology Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
Jennifer D Sisler1 Pathology and Physiology Research Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
Vincent Castranova4 Department of Pharmaceutical Science, West Virginia University, Morgantown, West Virginia, USA.
Dale W Porter1 Pathology and Physiology Research Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
Ann F Hubbs1 Pathology and Physiology Research Branch, HELD, National Institute for Occupational Safety and Health, Morgantown, West Virginia, USA.
National Institute for Occupational Safety and Health · USWest Virginia University · US

Funding

Intramural CDC HHS CC999999
6 · The paper itself

Abstract

Assessing the potential health risks for newly developed nanoparticles poses a significant challenge. Nanometer-sized particles are not generally detectable with the light microscope. Electron microscopy typically requires high-level doses, above the physiologic range, for particle examination in tissues. Enhanced dark-field microscopy (EDM) is an adaption of the light microscope that images scattered light. Nanoparticles scatter light with high efficiency while normal tissues do not. EDM has the potential to identify the critical target sites for nanoparticle deposition and injury in the lungs and other organs. This study describes the methods for EDM imaging of nanoparticles and applications. Examples of EDM application include measurement of deposition and clearance patterns. Imaging of a wide variety of nanoparticles demonstrated frequent situations where nanoparticles detected by EDM were not visible by light microscopy. EDM examination of colloidal gold nanospheres (10-100 nm diameter) demonstrated a detection size limit of approximately 15 nm in tissue sections. EDM determined nanoparticle volume density was directly proportional to total lung burden of exposed animals. The results confirm that EDM can determine nanoparticle distribution, clearance, transport to lymph nodes, and accumulation in extrapulmonary organs. Thus, EDM substantially improves the qualitative and quantitative microscopic evaluation of inhaled nanoparticles.

Indexed as

AnimalsInhalation ExposureLungMaleMiceMice, Inbred C57BLMicroscopyNanoparticlesRatsRats, Sprague-DawleyTissue Distributionfibrosisinhalationnanoparticlesnanotechnologypathologytoxicology

Identifiers

PMID28929951
PMCPMC6380170
OpenAlexW2755578587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.